Company profile
UK company 08027459, incorporated on 12 April 2012.
Home Page - Aptamer Group
Rapid Optimer development as antibody alternatives for therapeutic, drug delivery, diagnostics and bioprocessing.
Company number 08027459
Updated 07 Jul 2026 09:49
Financial period: 1 Jul 2024 to 30 Jun 2025
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
I am adding this here because Dr David Bunka one of the founders of this company trained with me as a postgraduate and a post-doctoral fellow in robotic aptamer selection. Subsequently with his co-founder, Dr Aaron Tolley, who trained with my former post-doctoral fellow, Prof Nicola Stonehouse, they founded Aptamer Solutions a start-up based on the science park in York. Their company which has supplied aptamers largely to the UK marketplace just had its first public offering a few months ago. None of this would have been possible without the training opportunities offered by these grants.
See above, this is now a listed company.
